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The adult mammalian central nervous system (CNS) has very limited regenerative
capacity upon neural injuries or under degenerative conditions. In recent years, however,
significant progress has been made on in vivo cell fate reprogramming for neural
regeneration. Resident glial cells can be reprogrammed into neuronal progenitors and
mature neurons in the CNS of adult mammals. In this review article, we briefly summarize
the current knowledge on innate adult neurogenesis under pathological conditions and
then focus on induced neurogenesis through cell fate reprogramming. We discuss how
the reprogramming process can be regulated and raise critical issues requiring careful
considerations to move the field forward. With emerging evidence, we envision that
fate reprogramming-based regenerative medicine will have a great potential for treating
neurological conditions such as brain injury, spinal cord injury (SCI), Alzheimer’s disease
(AD), Parkinson’s disease (PD), and retinopathy.
Keywords: in vivo reprogramming, adult neurogenesis, traumatic brain injury (TBI), spinal cord injury (SCI),
retinopathy, Alzheimer’s diseases (AD), Parkinson’s disease (PD)
INTRODUCTION
A functional central nervous system (CNS) consists of both neurons and glial cells. While neurons
are responsible for generating and communicating electrical and chemical signals essential for
neural networks, their activities are supported and modulated by surrounding glial cells (Rasband,
2016). Both neurons and glia can be affected by pathological conditions such as neural injuries
and degenerative diseases. Disruption of functional neural networks is frequently permanent and
is the underlying mechanism for many pathological symptoms for which no effective therapeutics
exists. An unmet challenge is how to promote neural regeneration for CNS repair after various
pathological conditions.
New neurons can be generated in the adult mammalian brain through a process of neurogenesis,
which is positively or negatively regulated by pathological conditions (Zhao et al., 2008). However,
innate neurogenesis is temporally and spatially restricted and is generally not sufficient for
functional neural repair.
In vivo neural reprogramming is emerging as a promising new strategy for regenerative
medicine (Chen et al., 2015; Smith and Zhang, 2015; Li and Chen, 2016; Smith et al., 2017;
Torper and Götz, 2017; Barker et al., 2018; Wang and Zhang, 2018). This strategy employs
genetic and epigenetic methods to reprogram resident glial cells into neuronal progenitors and
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FIGURE 1 | Innate and induced neurogenesis in the adult central nervous system. (A) Innate adult neurogenesis mainly occurs in the subgranular zone (SGZ) of the
hippocampal dentate gyrus and the subventricular zone (SVZ) of the lateral ventricle. Neural stem cells in these regions generate neurons under physiological and
certain pathological conditions. Neurons generated in the SGZ remain in the dentate gyrus, whereas neurons originated from SVZ migrate along the rostral migratory
stream (RMS) into the olfactory bulb. (B) Induced adult neurogenesis occurs through cell fate reprogramming in multiple regions of the brain, spinal cord, and retina.
Resident glial cells can be directly reprogrammed into mature neurons or progenitors. The induced progenitors can expand through proliferation and eventually give
rise to mature neurons. These induced neurons may integrate into the neural networks and promote functional recovery following neural injury or degeneration.
mature neurons in living animals. Unlike neurons that are
frequently lost in response to pathological conditions, glial cells
rather become activated and can form glial scars (Dixon, 2017;
Gitler et al., 2017; Hayta and Elden, 2018). Though reactive
glial cells may initially play beneficial roles, their persistent
activation and scar formation are in general believed to hinder
neural regeneration and may cause secondary damage to the
surrounding tissues (Oyinbo, 2011; Freire, 2012; Anderson et al.,
2016). In vivo fate reprogramming may turn reactive glial cells
into useful neurons for damaged tissues.
Here, we will briefly review pathological regulations of
innate neurogenesis and then focus on cell fate reprogramming
for induced neurogenesis in the adult mammalian CNS
(Figure 1).
PATHOLOGICAL MODULATION OF THE
INNATE NEUROGENESIS
Decades of research showed that neurogenesis persists in
restricted adult brain regions of many mammalian species:
the subventricular zone (SVZ) of the lateral ventricle and the
subgranular zone (SGZ) of the hippocampal dentate gyrus (DG;
Zhao et al., 2008; Ziemka-Nałecz and Zalewska, 2012; Obernier
et al., 2018). The adult neurogenesis process could be modulated
by neural injuries and pathological conditions.
Traumatic brain injury (TBI) triggers rapid cell death
predominantly in the cerebral cortex followed by secondary
tissue loss in the hippocampus. TBI-induced changes in adult
neurogenesis are well observed in rodents (Urrea et al., 2007;
Wang X. et al., 2016). Such changes are further shown to be
dependent on TBI severity (Wang X. et al., 2016). Both mild
and moderate TBI are not sufficient to induce new neurons
through neurogenesis, even though moderate TBI can promote
the proliferation of innate neural stem cells. Only severe TBI
can lead to enhanced neurogenesis indicated by both neural
stem cell proliferation and the formation of new neurons. Very
interestingly, studies of 11 human brain specimens showed that
TBI induced proliferation of cells expressing markers for neural
stem cells in the perilesional cortex of human brains, although
whether new neurons are generated remains to be determined
(Zheng et al., 2013).
Disruption of adult brain neurogenesis may represent a
critical feature in many neurological diseases. Epilepsy, for
example, modulates many cellular steps of adult neurogenesis
including stem cell proliferation and migration and integration
of newborn neurons (Jessberger and Parent, 2015). Adult
neurogenesis was observed to be enhanced in the hippocampus
of human patients with Alzheimer’s disease (AD) and a mouse
AD model (Jin et al., 2004a,b), whereas other mouse AD models
rather showed decreased hippocampal neurogenesis (Donovan
et al., 2006; Zhang et al., 2007). Adult hippocampal neurogenesis
is similarly dysregulated in human Parkinson’s disease (PD) and
mouse models of PD (Desplats et al., 2012; Winner et al., 2012;
He and Nakayama, 2015).
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Unlike the brain in which the phenomenon of adult
neurogenesis is well-established, the spinal cord lacks any
intrinsic ability to generate new neurons in adulthood (Horner
et al., 2000). Spinal cord injury (SCI) can lead to the proliferation
of multiple cell types including astrocytes and NG2 glia (also
known as oligodendrocyte progenitor cells). However, none of
these cells has been convincingly shown to generate mature
neurons in vivo (Yamamoto et al., 2001; Horky et al., 2006).
SCI also induces the proliferation of ependymal cells lining the
central canal. When isolated and cultured in vitro, these cells
exhibit stem cell-like properties that can form neurospheres and
give rise to neurons, astrocytes, and oligodendrocytes (Meletis
et al., 2008). Nevertheless, only astrocytes and oligodendrocytes
are produced from injury-activated ependymal cells under
in vivo conditions (Barnabé-Heider et al., 2010). It should be
noted that, however, such a stem cell-like role of ependymal
cells was recently questioned. The data from using more
stringent genetic lineage tracing mouse lines rather showed that
ependymal cells in either the adult brain or spinal cord lack
any properties of stem cells and rarely contribute new cells
to the injury site (Ren et al., 2017; Muthusamy et al., 2018;
Shah et al., 2018).
INDUCED NEUROGENESIS THROUGH
FATE REPROGRAMMING IN VIVO
Because of the restricted neurogenesis in the adult brain
and a lack of any neurogenesis in the adult spinal cord,
new strategies are devised to promote neural regeneration
under neuropathological conditions. One emerging regenerative
strategy is to reprogram the cell fate in vivo for the generation
of new neurons. Such in vivo reprogramming is largely driven by
ectopic expression of fate-determining transcriptional regulators.
Functionally mature new neurons can be generated through this
approach in several regions of the adult CNS (Table 1).
Induced Neurons After Brain Injury
Through in vivo screens of eight transcription factors (ASCL1,
BRN2, KLF4, MYC, MYT1L, OCT4, SOX2, and ZFP521) and
four microRNAs (miR9, miR124, miR125, and miR128), the
stem cell factor SOX2 was identified to be sufficient to
reprogram resident astrocytes into functional neurons in the
adult mouse striatum (Niu et al., 2013). These induced neurons
fire action potentials and make synaptic connections with
other local neurons. Subsequent studies revealed that SOX2-
mediated in vivo reprogramming passes through an expandable
neural progenitor stage that is capable of generating multiple
neurons from a single reprogrammed glia (Niu et al., 2015).
Mechanistically, SOX2 induces the expression of transcription
factors Ascl1 and Tlx, each of which is essential to the
reprogramming process (Islam et al., 2015; Niu et al., 2015). In
addition to astrocytes, Sox2 alone is also sufficient to convert
cortical NG2 glia into neurons especially following stab wound
injury (Heinrich et al., 2014).
Glial cells can also be directly converted into neurons
without passing through an expandable progenitor stage
in the adult brain after injury. Such reprogramming is
achieved by ectopic expression of transcription factors that
are shown to play key roles during normal neurogenesis.
Retrovirus-mediated expression of Neurod1 can efficiently
convert cortical astrocytes or NG2 glia into functional neurons
after brain injury (Guo et al., 2014). Very interestingly,
cortical astrocytes were mainly converted into glutamatergic
neurons, while NG2 glia were reprogrammed into both
glutamatergic and GABAergic neurons. On the other hand,
striatal microglia was recently shown to be reprogrammed by
Neurod1-expressing lentivirus into DARPP32+ medium spiny
neurons (Matsuda et al., 2019). Together, these results indicate
that cellular context has a great influence on the identity of the
induced neurons.
Recent data further showed that the efficiency of Neurod1-
mediated in vivo reprogramming of astrocytes could be
significantly enhanced when Neurod1 was delivered through
an AAV system (Zhang et al., 2018; Chen et al., 2020). Both
endothelin1-induced ischemia cortical stroke and stab wound-
induced cortical injury were shown to be nearly completely
repaired. Remarkably, the regenerated neurons exhibited cortical
layer-specific identities, formed functional neural circuits and
rescued motor and memory deficits. Neurod1-mediated efficient
neuronal conversion of astrocytes also leads to the regeneration
of beneficial astrocytes, restoration of blood-brain-barriers, and
reduction of neuroinflammation. Such broad and remarkable
effects of Neurod1-dependent reprogramming of resident
astrocytes, if confirmed, will revolutionize the therapeutic
strategies for brain injuries.
Other neurogenic factors including Neurog2 and Ascl1
are also individually capable of inducing new neurons in
the adult mouse brain (Grande et al., 2013; Liu et al.,
2015; Gascon et al., 2016). The Neurog2-mediated in vivo
reprogramming could be significantly enhanced by local
exposure to growth factors or by co-expression of Bcl-2
and anti-oxidative treatments (Grande et al., 2013; Gascon
et al., 2016). The latter treatments were revealed to act
through inhibition of the lipid peroxidation-mediated ferroptosis
pathway (Gascon et al., 2016). In addition to single factor-
mediated fate reprogramming, the combination of Ascl1 with
Brn2 and Myt1l through AAV-mediated expression also led
to the conversion of striatal astrocytes or NG2 glia to
neurons that could functionally integrate into the local circuits
(Torper et al., 2013; Pereira et al., 2017). Upon stab wound
injury, AAV-mediated expression of Neurog2 and Nurr1 in a
Cre-dependent manner can robustly convert cortical astrocytes
into functional pyramidal neurons (Mattugini et al., 2019).
Remarkably, these induced pyramidal neurons exhibit cortical
layer-specific identity indicated by lamina-specific marker
expression and long-distance axonal projections. It will be
extremely interesting to investigate whether these new cortical
neurons can lead to functional improvements after TBI.
After TBI and retrovirus-mediated ectopic expression of the
reprogramming OSKM factors (Oct4, Sox2, Klf4, and cMyc),
cells resembling induced pluripotent stem cells (iPSCs) could be
induced from reactive glial cells in the injured cortex (Gao et al.,
2016). These cells extensively proliferated and spontaneously
differentiated into neural stem cells and neurons. Such extensive
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TABLE 1 | Induced neurogenesis in the adult central nervous system.
Region/Disease model Cell source Reprogramming factors Functional properties of the
induced neurons
References
Cortex/Stab injury; AD Glia Neurod1 Functional synapses with surrounding
neurons
Guo et al. (2014)
Cortex/Stab injury NG2 glia Sox2 Synaptic inputs from innate neurons
near the injury site
Heinrich et al. (2014)
Cortex/Stab injury Glia Neurog2; Bcl-2; α-Tocotrienol Complex morphology Gascon et al. (2016)
Cortex/Controlled cortical impact injury Glia Oct4; Klf4; Sox2;c-Myc Electrophysiology; network-integration;
reduction of tissue cavity
Gao et al. (2016)
Cortex/Stab injury Astrocytes Neurod1 Brain repair with a reduction of tissue
loss
Zhang et al. (2018)
Cortex/Stab Injury Astrocytes Neurog2; Nurr1 Cortical layer-specific identity; synaptic
connections; long axonal projections
Mattugini et al. (2019)
Cortex/Ischemic injury Astrocytes Neurod1 Synaptic connections; long-range
axonal projections; improvement of
motor and cognitive functions
Chen et al. (2020)
Striatum/Injection injury Astrocytes SOX2 Electrophysiology; network integration Niu et al. (2013)
Striatum/6-OHDA lesion Human embryonic Ascl1; Brn2a; Myt1l Innervation into host tissues Torper et al. (2013)
fibroblasts/human fetal lung fibroblast
Striatum/Injection injury Astrocytes SOX2 Network-integration with inputs from
presynaptic neurons
Niu et al. (2015)
Striatum/Injection injury NG2 glia Ascl1; Lmx1a; Nurr1 Innervation from pre-existing local
circuitry
Torper et al. (2015)
Striatum; midbrain/6-OHDA NG2 glia Ascl1; Lmx1a; Nurr1; etc. Electrophysiology; network integration Pereira et al. (2017)
Striatum/PD Astrocytes Neurod1; Ascl1; Lmx1a;
miR218
Electrophysiology; rescue of
spontaneous motor behavior
Rivetti di Val Cervo et al. (2017)
Striatum/PD Astrocytes Ascl1; Pitx3; Lmx1a; Nurr1 Electrophysiology; rescue of
Parkinsonian phenotypes
Yoo et al. (2017)
Striatum/Injection injury Striatal neurons SOX2; NURR1; FOXA2;
LMX1A; Valproic acid
Electrophysiology; network integration Niu et al. (2018)
Striatum/Injection injury Microglia Neurod1 Integration into brain circuits with
synaptic connections.
Matsuda et al. (2019)
Striatum; Cortex/Stab injury; ischemia Non-neuronal cells Neurog2; growth factors Region-specific differentiation Grande et al. (2013)
Dorsal midbrain; Striatum; Cortex/Stab or injection injury Astrocytes Ascl1 Electrophysiology; network integration Liu et al. (2015)
Dentate gyrus/AD Astrocytes microRNA-302/367 Electrophysiology; improvement of
spatial learning and memory
Ghasemi-Kasman et al. (2018)
Spinal cord/SCI Astrocytes SOX2 Synapse-forming interneurons Su et al. (2014)
Spinal cord/SCI Astrocytes SOX2 Synaptic connections with local
neurons
Wang L. L. et al. (2016)
Retina/Retinal injury Müller glia Ascl1 Amacrine, bipolar, or photoreceptors Ueki et al. (2015)
Retina/Retinal injury Müller glia Ascl1; Trichostatin-A Inner retinal neurons; synapses with
host retinal neurons; response to light
Jorstad et al. (2017)
Retina/Congenital blindness Müller glia β-catenin; Otx2; Crx; Nrl Rod photoreceptors; restoration of
visual responses
Yao et al. (2018)
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proliferation and neural differentiation of iPSCs may be needed
to fill in the cavity caused by TBI; however, tumorigenesis and
simultaneous generation of non-neural cells in the brain need to
be prevented for this approach to be useful for brain repair.
Induced Neurons for Alzheimer’s Disease
Because of the progressive and pleiotropic neurodegeneration
observed in AD, local induction of new neurons as a therapeutic
approach may be challenging for this type of neurologic disease.
Nonetheless, in vivo reprogramming of reactive glial cells into
neurons were attempted in mouse models of AD. Similar to
acute brain injuries, AD and other neurodegenerative diseases
are frequently accompanied by reactive astrocytosis. The reactive
astrocytes were capable of being reprogrammed into neurons by
ectopic expression of Neurod1 in the cortex of 5xFAD mice (Guo
et al., 2014). Electrophysiological recordings of induced neurons
in 5xFAD brain slices showed that the induced neurons were
functional and made synaptic connections with surrounding
neurons. Interestingly, the number of Neurod1-induced neurons
was higher in aged and diseased brains than in young and
healthy ones, suggesting that more reactive glial cells observed
in aged and diseased brains might provide more cells for
reprogramming in vivo (Guo et al., 2014). In another AD
mouse model that was induced by intraventricular injection of
streptozocin, miR-302/367 ectopic expression in combination
with valproate treatment was reported to induce neurons from
reactive astrocytes in the dentate gyrus (Ghasemi-Kasman et al.,
2018). Such treatments also led to improved performance on
a behavioral task measuring spatial learning and memory,
implicating a new therapeutic strategy for AD patients.
Induced Neurons for Parkinson’s Disease
The cellular basis for PD is the loss of dopaminergic neurons
in the midbrain. Transplantation of this type of neurons
ameliorated many pathological symptoms associated with PD.
This raised the possibility that new dopaminergic neurons
derived from fate reprogramming in vivo may be a therapeutic
alternative to cell transplantation. Several studies explored the
feasibility of inducing new dopaminergic neurons in the adult
mouse brains. A combination of Ascl1, Lmx1a, and Nurr1 (ALN)
was shown to be sufficient to reprogram mouse fibroblasts
and astrocytes into dopaminergic neurons in culture (Addis
et al., 2011; Caiazzo et al., 2011). When this combination
was introduced into the adult mouse striatum, however, it
completely failed to induce any dopaminergic neurons from
either astrocytes or NG2 glia (Torper et al., 2015). Subsequent
studies further revealed that ALN or many other combinations
of fate-determining factors also failed to induce dopaminergic
neurons, although they could very robustly convert resident
NG2 glia into interneurons in the striatum (Pereira et al., 2017).
In contrast, in a mouse PD model that was induced
by 6-hydroxydopamine (6-OHDA), striatal astrocytes were
reported to be directly converted into dopaminergic neurons
when a cocktail of four transcription factors (Neurod1, Ascl1,
Lmx1a, and miR218) was delivered into the ipsilateral
striatum (Rivetti di Val Cervo et al., 2017). The in vivo
induced dopaminergic neurons were excitable and ameliorated
some aspects of motor deficits such as gait impairments.
Using a different set of transcription factors (Ascl1, Pitx3,
Lmx1a, and Nurr1) and in combination with electromagnetic
gold nanoparticles (AuNPs) and the presence of specific
electromagnetic fields, Yoo et al. (2017) reported that
dopaminergic neurons could be converted from resident
striatal astrocytes in MPTP- or 6-OHDA-induced PD mouse
models. Importantly, such combinatorial treatments also
alleviated locomotor deficits that were observed in these mouse
PD models. Results of the above two reports showed the
therapeutic potential of in vivo reprogrammed dopaminergic
neurons for PD.
Taking a slightly different strategy, Niu et al. (2018) reported
that functional dopaminergic neurons could also be generated
in the adult mouse striatum. Unexpectedly, systematic lineage
mappings in several transgenic mouse lines rather discovered
that these induced dopaminergic neurons were originated from
resident striatal neurons but not from any glial cells. Such
phenotypic reprogramming revealed unprecedented plasticity of
mature neurons and implicated an alternative strategy to rewire
brain circuits in the adult. It will be interesting to determine
the biological effect of such reprogrammed dopaminergic
neurons in PD.
Induced Neurons After Spinal Cord Injury
Spinal cord injuries (SCI) lead to the disruption of neural
circuits and the loss of propriospinal neurons. The addition of
new neurons may well serve as relays that could form neural
circuits for functional improvements. Ectopic expression of
SOX2 induced DCX+ neuroblasts in the adult spinal cord after
injury (Su et al., 2014). Lineage tracing confirmed an astrocyte
origin for the induced neuroblasts. These neuroblasts could
expand through proliferation and eventually become mature
neurons that formed connections with spinal motor neurons.
Through in vivo screens of additional 17 factors, the p53-p21
signaling pathway was identified to be critical for controlling the
expansion of SOX2-induced neuroblasts in the adult spinal cord
(Wang L. L. et al., 2016). Downregulation of either p53 or p21 led
to a greatly increased number of SOX2-induced neuroblasts
and mature neurons. The ability to expand the number of
induced neurons may be therapeutically advantageous since a
SCI frequently leads to the death of many propriospinal neurons.
Interestingly, a majority of these SOX2-induced neurons are
VGLUT2+ excitatory interneurons (Wang L. L. et al., 2016),
which are in sharp contrast to those in the striatum that are
mainly GABAergic interneurons (Niu et al., 2015). VGLUT2+
interneurons are essential components of the locomotor circuitry
and play an important role in the proper organization of the
spinal locomotor network (Borgius et al., 2014). As such, it is
conceivable that the induced VGLUT2 excitatory interneurons
may well be capable of forming relay circuits (Courtine et al.,
2008; Abematsu et al., 2010) with ascending and descending
pathways that are frequently disrupted by SCI.
Induced Neurons for Retinopathy
Müller glial cells (MGs) are the major glial cells in the retina, an
integral part of the mammalian CNS that lacks any neurogenesis
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under both physiological and pathological conditions. Ectopic
Ascl1 in young transgenic mice renders MGs to generate retinal
neurons including amacrine and bipolar cells and photoreceptors
after injury (Ueki et al., 2015). However, such Ascl1-mediated
reprogramming of MGs is restricted to the first 2 weeks after
birth. An epigenetic barrier may account for the reprogramming
failure of adult MGs since the chromatin is less accessible in
these cells than those young MGs (Ueki et al., 2015). Indeed,
when treated with a histone deacetylase inhibitor that leads to
increased histone acetylation and an open chromatin structure,
ectopic Ascl1 can reprogram MGs to generate retinal neurons
after retinal injury in the adult mice (Jorstad et al., 2017).
Importantly, these induced neurons can make synapses with
resident neurons and respond to light stimulation, indicating
functional integration into the neural network. It is not clear,
though, why the induce neurons are mainly bipolar cells, since
lineage tracing shows that Ascl1-expressing progenitors can
give rise to multiple neuronal subtypes during retinogenesis
(Brzezinski et al., 2011).
Taking a two-step approach, Yao et al. (2018) show that
activated MGs can be directly reprogrammed into functional
rod photoreceptors in the adult mice. AAV-mediated ectopic
expression of β-catenin enables the adult MGs to proliferate
without prior injury (Yao et al., 2016). However, a majority of
these activated MGs undergo cell death and rarely generate any
new retinal neurons. Remarkably, subsequent AAV-mediated
expression of Otx2, Crx, and Nrl in these activated MGs allows
them to produce rod photoreceptors, which are capable of
restoring visual responses in a mouse model of congenital
blindness (Yao et al., 2018). It will be certainly interesting to
examine whether other retinal cell types, such as retinal ganglion
cells, can be similarly reprogrammed from MGs by using a
different set of fate-determining factors.
THE INFLUENCE OF CELLULAR CONTEXT
ON FATE REPROGRAMMING
Emerging evidence indicates that cellular contexts, such as
senescence, mitochondria dynamics, and autophagy, play critical
roles during the reprogramming process.
Senescence
Senescence is characterized by permanent cell cycle arrest. Cells
in senescence secrete inflammatory cytokines, chemokines, and
growth factors that are together referred to as the senescence-
associated secretory phenotype (SASP; Childs et al., 2015).
Senescence plays critical roles in tissue repair, embryonic
development, as well as aging-related diseases (Loeser, 2009;
Storer et al., 2013; Demaria et al., 2014). In a transgenic mouse
model expressing the reprogramming OSKM factors for iPSCs,
the extent of cell senescence is found to be positively correlated
with the efficiency of cell reprogramming in vivo (Mosteiro
et al., 2016). OSKM-induced senescent cells secrete interleukin-
6, which creates a favorable microenvironment that facilitates
reprogramming in adult mice. Mechanistic studies further reveal
that Ink4a is critical for the induction of cell senescence and
reprogramming; however, it is dispensable when p53 is removed
(Mosteiro et al., 2018). Consistent with a positive role of cell
senescence, the frequency of OSKM-induced reprogramming is
increased in aged mice (Mosteiro et al., 2016).
Mitochondrial Dynamics
Mitochondrion plays critical roles in many cellular processes,
such as metabolism, energy production, generation of reactive
oxygen species (ROS), cell signaling, and apoptosis (Sarsour
et al., 2009; Osellame et al., 2012). It is also emerging as a key
player in cell fate determination, maintenance of pluripotency,
and cell reprogramming (Folmes et al., 2012; Maryanovich and
Gross, 2013; Prieto and Torres, 2017). Mitochondrial respiratory
dysfunction triggered by mutant mtDNAs blocks cellular
reprogramming, though it does not affect the maintenance of
the pluripotent state (Yokota et al., 2015). Direct reprogramming
of somatic cells to neurons induces a metabolic switch that
leads to high levels of oxidative stress and ferroptosis-dependent
cell death. As such, reduction of ROS through Bcl-2 ectopic
expression or treatments with antioxidants potently promote
neuronal reprogramming both in culture and in a mouse model
of TBI (Gascon et al., 2016). On the other hand, mitochondrial
fission accompanies the early phase of cell reprogramming
(Prieto et al., 2016). Blocking the pro-fission factor Drp1 hinders
the production of iPSCs. It should be interesting to examine
whether mitochondria dynamics are associated with neural
reprogramming in the adult CNS.
Autophagy
Autophagy is a cellular process that degrades cytoplasmic
components and organelles by the lysosome to maintain cellular
homeostasis (Mizushima and Levine, 2010). Recent in vitro
and in vivo studies reveal critical roles of autophagy in the
regulation of adult neurogenesis and reprogramming (Tang,
2013; Wang et al., 2015). Conditional deletion of Fip200, an
essential gene for the induction of mammalian autophagy, leads
to impaired autophagy, increased mitochondrial number, and
elevated ROS in postnatal mouse neural stem cells. Consequently,
stem cell maintenance and neuronal differentiation are severely
impaired in these mice; and, such impairments can be rescued
by reducing ROS levels through treatments with an antioxidant
(Wang et al., 2013). Beclin1, a gene required for autophagosome
formation, is similarly required for adult neurogenesis in the
lateral ventricle (Yazdankhah et al., 2014). On the other hand,
iPSC reprogramming requires mitochondrial clearance mediated
by the AMPK-dependent but Atg5-independent autophagic
process (Ma et al., 2015). It remains to be determined what roles
of autophagy play during neural reprogramming in vivo.
ISSUES TO CONSIDER
Despite the recent major progresses, several key issues
require considerations to move forward the field of neural
reprogramming in vivo.
Cell Origin for Reprogrammed Neurons
The cell origin for the induced neurons requires thorough
investigation and confirmation. Unlike in vitro reprogramming
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that can start from a relatively pure population of cells and the
fate-switch can be directly observed under a microscope, in vivo
reprogramming occurs in a very complex microenvironment
consisting of multiple cell types including resident neurons. It
is essential to use well-established lineage tracing methods or
time-lapse imaging to follow the reprogramming process and
confirm the cell origin for the induced neurons (Niu et al., 2013,
2018; Heinrich et al., 2014; Pilz et al., 2018). If the induced
neurons originate from reactive and proliferative glial cells, the
BrdU- or EdU-based labeling method is a simple and validated
way to confirm that the induced neurons are indeed newly
generated (Grande et al., 2013; Niu et al., 2013; Heinrich et al.,
2014; Wang L. L. et al., 2016; Mattugini et al., 2019). Based on
our years’ experiences working with lentiviruses and AAVs, it
is not reliable to use the virus-based reporters as a sole tracing
method for in vivo induced neurons. Despite using cell-type-
specific promoters (such as the human GFAP promoter), the
attached sequences (such as GFP vs. reprogramming factors)
can significantly affect cell specificity, consistent with a previous
report in transgenic mice (Su et al., 2004). Retroviruses, on the
other hand, can induce fusion of virus-transduced microglia
with resident mature neurons (Ackman et al., 2006). As such,
experiments should be conducted to exclude the possibility that
resident neurons are mistakenly considered as induced neurons.
Molecular and Cellular Mechanisms
Underlying Neural Reprogramming in vivo
Emerging evidence indicates that multiple pathways regulate the
in vivo reprogramming process. The neurogenic factor Ascl1 and
the nuclear receptor Tlx are found to be essential mediators
of SOX2-dependent reprogramming of astrocytes in the adult
brain (Niu et al., 2015). Through a series of in vivo screens,
the p53-p21 pathway was identified to function as a critical
checkpoint for glial reprogramming in the adult mouse spinal
cord (Wang L. L. et al., 2016). Neurog2-mediated direct neuronal
reprogramming can be remarkably promoted by a cocktail
of growth factors or coexpression of Bcl-2 and anti-oxidative
treatments in the adult brain (Grande et al., 2013; Gascon et al.,
2016). Reprogramming of microglia by Neurod1 is accompanied
by changes in the epigenetic landscape, which gradually leads
to loss of microglial traits and acquisition of neuronal identity
(Matsuda et al., 2019). Inhibition of histone deacetylases, which
promotes chromatin accessibility, is required for Ascl1 to convert
adult MGs into neurons in the injured retina (Jorstad et al.,
2017). With recent advancements in Omics tools, such as
scRNA-seq, ChIP-seq, and ATAC-seq, more molecular details
on the reprogramming process are expected to emerge shortly.
Cautions should be taken, however, when extrapolating results
from cell culture models, since many of them might not be
reproducible under in vivo conditions. For example, both mouse
fibroblasts and astrocytes can be efficiently reprogrammed into
dopaminergic neurons in culture (Addis et al., 2011; Caiazzo
et al., 2011). These same reprogramming factors, nonetheless,
completely failed to induce any dopaminergic neurons from
glial cells in the adult mouse brain (Torper et al., 2015;
Pereira et al., 2017).
Intriguingly, various glial cells can be efficiently
reprogrammed by diverse factors into brain region-specific
neuronal subtypes. For example, a combination of Neurog2
and Nurr1 reprograms adult astrocytes into diverse neuronal
subtypes with cortical layer-specificity and precise long-distance
axonal projections (Mattugini et al., 2019). Such feats can be
similarly accomplished by ectopic expression of Neurod1 in
the adult cortex with or without prior injury (Chen et al.,
2020; Liu et al., 2020). In the adult striatum, Neurod1 can
efficiently reprogram both astrocytes and microglia into mature
striatal neurons (Matsuda et al., 2019; Liu et al., 2020). These
striatal neurons can also be converted from oligodendrocytes
by microRNA-mediated knockdown of Ptbp1 (Weinberg et al.,
2017). How do these different reprogramming factors generate
similar or identical subtypes of neurons from reactive or
non-reactive astrocytes, microglia, and oligodendrocytes? How
is region-specificity established for the glia-converted neurons?
Do these diverse glial cells retain brain region-specificity that
potentially mediates such phenomenal fate-switch when a
neurogenic factor is ectopically expressed? If so, how could
they still maintain region- and subtype-specificity after brain
injury? How could microglia, which is not even derived
from the neural lineage, be efficiently reprogrammed into
neuronal subtypes as those from astrocytes by the same
reprogramming factor such as Neurod1? Since most, if not all,
of the developmental cues for axon guidance, are diminished
in the adult CNS, how do these newly reprogrammed neurons
make precise axonal projections especially after neural injuries?
Answers to these questions will provide critical insights
into the cellular mechanisms for neural reprogramming
in vivo.
Biological Functions of Neural
Reprogramming
In vivo neural reprogramming has shown promising biological
functions for stroke-induced brain injury (Chen et al., 2020),
chemical-induced PD (Rivetti di Val Cervo et al., 2017; Yoo et al.,
2017), and a genetic mouse model of blindness (Yao et al., 2018).
If confirmed, these advancements will bring unprecedented
regeneration-based therapies for many other neural injuries
and neurological diseases. Nonetheless, these new neurons may
not lead to the recovery of lost memories, although they may
help form new ones. It remains unclear what role of newly
reprogrammed neurons play during functional recovery since
the reprogramming of glial cells not only produces new neurons
but also alters the microenvironment. After an injury or under
degenerative conditions, reactive gliosis play critical roles in
modulating tissue damage and neural regeneration (Okada et al.,
2006; Sofroniew, 2009; Robel et al., 2011; Karimi-Abdolrezaee
and Billakanti, 2012). Of note, scar formation and secretion
of chondroitin sulfate proteoglycans (CSPG) by reactive glial
cells are inhibitory for functional improvement post neural
injury. Attenuation of reactive gliosis or reducing CSPG activity
improves post-traumatic regeneration (Wilhelmsson et al., 2004;
Lang et al., 2015), whereas increasing reactive gliosis worsens
brain injuries (Mori et al., 2008). As such, it will be interesting
to tease out the respective contributions of new neurons and
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the environmental changes to functional recovery post injuries
or degenerations. On the other hand, it also remains to be
determined whether glia-converted neurons play any detrimental
effect, since these new neurons may well lead to disruption
of preexisting neural circuits or formation of abnormal ones.
Rehabilitation may be needed for the new neurons to incorporate
into functional neural circuits.
CONCLUDING REMARKS
In vivo neural reprogramming has achieved impressive progress,
ranging from generation of diverse glia-converted neurons in
multiple CNS regions to functional improvements for certain
neurological conditions. Such a reprogramming-based approach
may kill two birds with one stone: regeneration of functional
neurons and modulation of pathological microenvironment.
Nonetheless, efforts should be taken to vigorously validate
the cell origin for the claimed new neurons and to tease
out the molecular and cellular mechanisms underlying the
reprogramming progress. The results of these efforts will
lay a solid scientific foundation to move in vivo cell fate
reprogramming towards neural repair.
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